Salvage treatment with infliximab of steroid-resistant graft-versus-host disease in allogeneic transplanted patients;Tratamiento de rescate con infliximab de la enfermedad del injerto contra el huésped resistente a glucocorticoides

Medicina Clinica

Volumn 137, Issue 3, 2011, Pages 115-118

  Motlló, Cristina ^a   Ferrà, Christelle ^a   López, Laia ^b   Morgades, Mireia ^a   Batlle, Montserrat ^a   Ribera, Josep Maria ^a  

^a UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

^b CATALAN INSTITUTE OF ONCOLOGY   (Spain)

Author keywords

Failure to glucocorticoids; Graft versus host disease; Infections; Infliximab

Indexed keywords

INFLIXIMAB; STEROID;

ALLOTRANSPLANTATION; ARTICLE; ASPERGILLOSIS; BLOOD; CLINICAL ARTICLE; CLINICAL EVALUATION; DRUG ACTIVITY; DRUG EFFICACY; GRAFT SALVAGE; GRAFT VERSUS HOST REACTION; HUMAN; NONHUMAN; PSEUDOMONAS INFECTION; RETROSPECTIVE STUDY;

ADOLESCENT; ADRENAL CORTEX HORMONES; ADULT; AGED; ANTIBODIES, MONOCLONAL; ASPERGILLOSIS; ASPERGILLUS FUMIGATUS; CORD BLOOD STEM CELL TRANSPLANTATION; DRUG RESISTANCE; FEMALE; FUNGEMIA; GRAFT VS HOST DISEASE; HEMATOLOGIC NEOPLASMS; HUMANS; IMMUNOSUPPRESSIVE AGENTS; MALE; MIDDLE AGED; PERIPHERAL BLOOD STEM CELL TRANSPLANTATION; PSEUDOMONAS AERUGINOSA; PSEUDOMONAS INFECTIONS; RETROSPECTIVE STUDIES; SALVAGE THERAPY; SEPSIS; TRANSPLANTATION, HOMOLOGOUS; YOUNG ADULT;

EID: 79958165479     PISSN: 00257753     EISSN: 15788989     Source Type: Journal    
DOI: 10.1016/j.medcli.2011.03.006     Document Type: Article

References (15)

1. Deeg JH. How I treat refractory acute GVHD. Blood. 2007;109:4119-26.
2. Hahn T, McCarthy Jr PL, Zhang MJ, Wang D, Arora M, Frangoul H, et al. Risk factors for acute graft-versus-host disease after human leukocyte antigen-identical sibling transplants for adults with leukemia. J Clin Oncol. 2008;26:5728-34.
3. Ballesteros M, Ferrá C, Serrano D, Batlle M, Ribera JM, Díez-Martín JL. Antithymocyte globulin therapy for steroid-resistant acute graft versus host disease. Am J Hematol. 2008;83:824-52.
4. Martínez C, Solano C, Ferrá C, Sampol A, Valcárcel D, Pérez-Simón JA, Spanish Group for Stem Cell Transplantation. Alemtuzumab as treatment of steroidrefractory acute graft-versus-host disease: results of a phase II study. Biol Bone Marrow Transplant. 2009;15:639-42.
5. Sleight BS, Chan KW, Braun TM, Serrano A, Gilman AL. Infliximab for GVHD therapy in children. Bone Marrow Transplant. 2007;40:473-80. (Pubitemid 47288228)
6. Wolff D, Steiner B, Hildebrandt G, Edinger M, Holleret E. Pharmaceutical and cellular strategies in prophylaxis and treatment of graft-versus-host disease. Curr Pharm Des. 2009;15:1974-97.
7. Bacigalupo A. Management of acute graft-versus-host disease. Br J Haematol. 2007;137:87-98. (Pubitemid 46474711)
8. Filipovich A, Weisdorf D, Pavletic S, Socie G, Wingard JR, Lee SJ. National Institutes of Health Consensus Development Project on criteria for clinical trials in chronic graft-versus-host disease: I. Diagnosis and Staging Working Group Report. Biol Blood Marrow Transplant. 2005;11:945-55.
9. Alousi A, Weisdorf DJ, Logan BR, Bolaños-Meade J, Carter S, DiFronzo N, et al. Etanercept, mycophenolate, denileukin, or pentostatin plus corticosteroids for acute graft-versus-host disease: a randomized phase 2 trial from the Blood and Marrow Transplant Clinical Trials Network. Blood. 2009;114:511-7.
10. Horwitz ME, Sullivan KM. Chronic graft-versus-host disease. Blood Rev. 2006;20:15-27. (Pubitemid 43106715)
11. Busca A, Locatelli F, Marmont F, Ceretto C, Falda M. Recombinant human soluble tumor necrosis factor receptor fusion protein as treatment for steroid refractory graft-versus-host disease following allogeneic hematopoietic stem cell transplantation. Am J Hematol. 2007;82:45-52. (Pubitemid 46033391)
12. Patriarca F, Sperotto A, Damián D, Morreale G, Bonifazi F, Olivieri A, et al. Infliximab treatment for steroid-refractory acute graft-versus-host disease. Haematologica. 2004;89:1352-9. (Pubitemid 39540573)
13. Jacobsohn DA, Hallick J, Anders V, McMillan S, Morris L, Vogelsang GB. Infliximab for steroid-refractory acute GVHD: A case series. Am J Hematol. 2003;74:119-24. (Pubitemid 37187728)
14. Couriel D, Saliba R, Hicks K, Ippoliti C, De LimaM, Hosing C, et al. Tumor necrosis factor-α blockade for the treatment of acute GVHD. Blood. 2004;104:649-54. (Pubitemid 38970556)
15. Marty FM, Lee SJ, Fahey MM, Alyea EP, Soiffer RJ, Antin JH, et al. Infliximab use in patients with severe graft-versus-host disease and other emerging risk factors of non-Candida invasive fungal infections in allogeneic hematopoietic stem cell transplant recipients: a cohort stud. Blood. 2003;102:2768-76. (Pubitemid 37258330)